Actual Medicinal Product (AMP) Aspirin 300mg tablets (Aspar Pharmaceuticals Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicines. Store in airtight (sealed) MCA). Protect from light. Manufacturer recommends storing in original container. Mixed results from stability studies but likely supports 5 weeks in sealed MCA when protected from moisture and light.
- Provenance
-
This recommendation is based on the products Aspirin 300mg Tablets (Accord-UK Ltd) and Aspirin 300mg Tablets BP (Bristol Laboratories Ltd).
- Generic
- Aspirin
- Formulation
- Aspirin 300mg tablets
-
Aspirin
-
Aspirin 300mg tablets
-
Aspirin 300mg tablets (Aspar Pharmaceuticals Ltd)
-
-
Aspirin 300mg gastro-resistant tablets